Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_assertion type Assertion NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_head.
- NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_assertion wasGeneratedBy ECO_0000203 NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_provenance.
- NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_assertion wasDerivedFrom befree-2016 NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_provenance.
- NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_assertion SIO_000772 16245282 NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_provenance.
- NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_assertion evidence source_evidence_literature NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_provenance.
- NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_assertion description "[A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519239.RA6Vu6kVfmfvwzdy84umTDEjozfObU37dHHk8tG-iHHSM130_provenance.